상세 보기
Acute Profound Thrombocytopenia after Using Abciximab for No-Reflow during Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
- Park, Soonyoung;
- Lee, Jooyoung;
- Lee, Sang Yeub;
- Bae, Jang-Whan;
- Hwang, Kyung-Kuk;
- 외 3명
Citations
WEB OF SCIENCE
2Citations
SCOPUS
5초록
Glycoprotein IIb/IIIa antagonists are well established for their effectiveness in improving clinical outcomes in acute coronary syndrome patients undergoing percutaneous coronary intervention. Acute profound thrombocytopenia is a rare complication of abciximab. We present a case which was managed successfully for the rare complication of acute profound thrombocytopenia after using abciximab and an intra-aortic balloon pump for the treatment of a no-reflow phenomenon and consecutive cardiogenic shock during primary percutaneous coronary intervention.
키워드
Thrombocytopenia; Abciximab; No-reflow phenomenon; GLYCOPROTEIN IIB/IIIA RECEPTOR; MANAGEMENT; BLOCKADE; HEPARIN; ANGIOPLASTY; TRIAL
- 제목
- Acute Profound Thrombocytopenia after Using Abciximab for No-Reflow during Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
- 저자
- Park, Soonyoung; Lee, Jooyoung; Lee, Sang Yeub; Bae, Jang-Whan; Hwang, Kyung-Kuk; Kim, Dong-Woon; Cho, Myeong-Chan; Kim, Sang Min
- 발행일
- 2013-08
- 유형
- Article
- 권
- 43
- 호
- 8
- 페이지
- 557 ~ 560
- 언어
- ENG
- 출판사
- KOREAN SOC CARDIOLOGY
- 발행국가
- 대한민국
- 분량
- 4 페이지
- ISSN
- E 1738-5555
P 1738-5520